Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: Stimulation by Thr-457 and inhibition by Ser-461

Experimental Cell Research

Volumn 315, Issue 7, 2009, Pages 1225-1233

  Li, Chunxia ^a   Chen, Charng Jui ^a   Shively, John E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; CEACAM1; Lumen formation; Phosphorylation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1 4L; MATRIGEL; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOPLASM; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE; MAMMARY GLAND; MOLECULAR MIMICRY; MORPHOGENESIS; MOUSE; MUTANT; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCID MOUSE; STIMULATION; WILD TYPE;

MUS;

ADIPOSE TISSUE; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; HUMANS; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED NOD; MICE, SCID; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SERINE; THREONINE;

EID: 63049131056     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.12.015     Document Type: Article

References (35)

1. Gray-Owen S.D., and Blumberg R.S. CEACAM1: contact-dependent control of immunity. Nat. Rev. Immunol. 6 (2006) 433-446
2. Kuespert K., Pils S., and Hauck C.R. CEACAMs: their role in physiology and pathophysiology. Curr. Opin. Cell Biol. 18 (2006) 565-571
3. Svenberg T., Hammarstrom S., and Zeromski J. Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues. Clin. Exp. Immunol. 36 (1979) 436-441
4. Obrink B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr. Opin. Cell Biol. 9 (1997) 616-626
5. Barnett T.R., Drake L., and Pickle II W. Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins. Mol. Cell. Biol. 13 (1993) 1273-1282
6. Sadekova S., Lamarche-Vane N., Li X., and Beauchemin N. The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases. Mol. Biol. Cell 11 (2000) 65-77
7. Schumann D., Chen C.J., Kaplan B., and Shively J.E. Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin. J. Biol. Chem. 276 (2001) 47421-47433
8. Edlund M., and Obrink B. Evidence for calmodulin binding to the cytoplasmic domains of two C-CAM isoforms. FEBS Lett. 327 (1993) 90-94
9. Blikstad I., Wikstrom T., Aurivillius M., and Obrink B. C-CAM (Cell-CAM 105) is a calmodulin binding protein. FEBS Lett. 302 (1992) 26-30
10. Brummer J., Ebrahimnejad A., Flayeh R., Schumacher U., Loning T., Bamberger A.M., and Wagener C. cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am. J. Pathol. 159 (2001) 537-546
11. Jin L., Li Y., Chen C.J., Sherman M.A., Le K., and Shively J.E. Direct interaction of tumor suppressor CEACAM1 with beta-catenin: identification of key residues in the long cytoplasmic domain. Exp. Biol. Med. 233 (2008) 849-859
12. Kirshner J., Schumann D., and Shively J.E. CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis. J. Biol. Chem. 278 (2003) 50338-50345
13. Singer B.B., Scheffrahn I., and Obrink B. The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res. 60 (2000) 1236-1244
14. Turbide C., Kunath T., Daniels E., and Beauchemin N. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res. 57 (1997) 2781-2788
15. Chen D., Iijima H., Nagaishi T., Nakajima A., Russell S., Raychowdhury R., Morales V., Rudd C.E., Utku N., and Blumberg R.S. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J. Immunol. 172 (2004) 3535-3543
16. Iijima H., Neurath M.F., Nagaishi T., Glickman J.N., Nieuwenhuis E.E., Nakajima A., Chen D., Fuss I.J., Utku N., Lewicki D.N., Becker C., Gallagher T.M., Holmes K.V., and Blumberg R.S. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199 (2004) 471-482
17. Izzi L., Turbide C., Houde C., Kunath T., and Beauchemin N. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18 (1999) 5563-5572
18. Riethdorf L., Lisboa B.W., Henkel U., Naumann M., Wagener C., and Loning T. Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J. Histochem. Cytochem. 45 (1997) 957-963
19. Huang J., Hardy J.D., Sun Y., and Shively J.E. Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J. Cell. Sci. 112 Pt. 23 (1999) 4193-4205
20. Luo W., Wood C.G., Earley K., Hung M.C., and Lin S.H. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene 14 (1997) 1697-1704
21. Strange R., Metcalfe T., Thackray L., and Dang M. Apoptosis in normal and neoplastic mammary gland development. Microsc. Res. Tech. 52 (2001) 171-181
22. McManaman J.L., and Neville M.C. Mammary physiology and milk secretion. Adv. Drug Deliv. Rev. 55 (2003) 629-641
23. Guinebretiere J.M., Menet E., Tardivon A., Cherel P., and Vanel D. Normal and pathological breast, the histological basis. Eur. J. Radiol. 54 (2005) 6-14
24. Kirshner J., Chen C.J., Liu P., Huang J., and Shively J.E. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 521-526
25. Yokoyama S., Chen C.J., Nguyen T., and Shively J.E. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation. Oncogene 26 (2007) 7637-7646
26. Chen C.J., Kirshner J., Sherman M.A., Hu W., Nguyen T., and Shively J.E. Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation. J. Biol. Chem. 282 (2007) 5749-5760
27. Huang J., Simpson J.F., Glackin C., Riethorf L., Wagener C., and Shively J.E. Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer Res. 18 (1998) 3203-3212
28. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., and Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4966-4971
29. Edlund M., Wikstrom K., Toomik R., Ek P., and Obrink B. Characterization of protein kinase C-mediated phosphorylation of the short cytoplasmic domain isoform of C-CAM. FEBS Lett. 425 (1998) 166-170
30. Gaur S., Shively J.E., Yen Y., and Gaur R.K. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms. Mol. Cancer 7 (2008) 46-57
31. Wagener C., Clark B.R., Rickard K.J., and Shively J.E. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. J. Immunol. 130 (1983) 2302-2307
32. Shi S.R., Cote R.J., and Taylor C.R. Antigen retrieval techniques: current perspectives. J. Histochem. Cytochem. 49 (2001) 931-937
33. Leers M.P., Kolgen W., Bjorklund V., Bergman T., Tribbick G., Persson B., Bjorklund P., Ramaekers F.C., Bjorklund B., Nap M., Jornvall H., and Schutte B. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187 (1999) 567-572
34. Caulin C., Salvesen G.S., and Oshima R.G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138 (1997) 1379-1394
35. Simpson P.T., Reis-Filho J.S., Gale T., and Lakhani S.R. Molecular evolution of breast cancer. J. Pathol. 205 (2005) 248-254